This pilot study explores the metabolic changes associated with persistent postconcussion syndrome (PCS) after mild traumatic brain injury (mTBI; > 12 months after injury) using magnetic resonance spectroscopy. We hypothesized that those mTBI participants with PCS will have larger metabolic differences than those without. Data were collected from mTBI participants with PCS, mTBI participants without PCS and non-head-injured participants (all groups: n = 8). Magnetic resonance spectroscopy metabolite profiles within the dorsolateral prefrontal cortex showed a reduced creatine/choline ratio in mTBI patients compared with control participants. This data provides initial evidence for residual metabolic changes in chronic mTBI patients, but there was no conclusive relationship between these metabolic changes and PCS symptom report. Creatine is involved in maintaining energy levels in cells with high or fluctuating energy demand, suggesting that there may be some residual energy impairment in chronic mTBI.
Introduction
Head injury induces a cascade of metabolic changes, which result in a generalized cellular energy crisis, and can lead to cell death or disruption in neural connectivity [1, 2] . It is thought that these mechanisms may underlie the symptoms [collectively known as postconcussion syndrome (PCS)] observed after mild traumatic brain injury (mTBI), with significant metabolic alterations occurring even in the absence of these symptoms [1] . Magnetic resonance spectroscopy (MRS [3] ) can be used to measure metabolite concentrations in vivo and investigate whether subtle differences caused by this metabolic cascade are still evident in the long term after injury. Creatine (Cr) is particularly suited for investigation of the energy metabolism after head injury. Impairment of the creatine/phosphocreatine (Cr/PCr) system can lead to a deterioration in energy metabolism resulting in symptoms similar to those seen in PCS such as predisposition to migraines [4] , mental retardation and other neurological symptoms [5] .
There have been variable observations of Cr concentration in acute mTBI, with higher concentrations generally seen in white matter [6, 7] , and no difference [8] in grey matter or mixed areas. This is despite the more consistent detection of lower levels of N-acetyl aspartate (NAA [9] ) and higher levels of choline (Cho) [7] , and some initial evidence of reduction in glutamine and glutamate in grey matter [3, 7] . There is a paucity of studies on Cr after head injury, and its concentration is conventionally thought to be stable in healthy indivi-duals. However, reduced Cr concentration has been observed in clinical populations such as those with cancer [10] and stroke [11] .
The present pilot study aims to investigate the long-term effect of mTBI (> 1 year postinjury) on metabolite concentrations in the dorsolateral prefrontal cortex (DLPFC, a grey matter area involved in cognitive functions) in those reporting persistent PCS and those without ongoing PCS. We conducted 3 T 1 H-MRS at short echo time, in conjunction with cognitive testing in 16 patients with mTBI (n = 8 for those with/without PCS) and eight non-head-injured controls. Only a few studies [8, 9, 12] have considered mTBI participants beyond the acute stage, and none have examined the association of PCS and metabolite concentrations in the long term. We hypothesized that mTBI patients with persistent PCS would show greater metabolic changes (in particular in metabolites related to energy processing) than both mTBI patients without PCS and non-head-injured controls.
Methods

Recruitment
Participants were recruited from a database created by previous studies [13, 14] , with mTBI diagnosis according to International Classification of Diseases, 10th Revision (ICD-10) criteria [15] . PCS diagnosis was based on the modified Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV) criteria (which does not include cognitive testing) by Mittenberg and Strauman [16] , and was achieved in the same way for control participants as mTBI participants (with the exception that controls had no 'history of head trauma'). Inclusion criteria were that injury occurred at least 1 year previously, and exclusion criteria were reports of litigation, major invasive head injury, chronic pain or other neurological conditions. None of the participants had visible lesions using standard structural MRI. Twentyfour participants were included in this study, divided into three groups containing eight participants each: mTBI + PCS (participants who suffered an mTBI and have persistent PCS); mTBI -PCS (participants with mTBI but no PCS); control (participants with no history of brain injury and no PCS). Group demographics and questionnaire data are shown in Table 1 . The study protocol was given a favourable opinion by the University of Surrey Ethics Committee, and informed consent was obtained from every participant. . Both water-suppressed spectra (256 averages) and spectra without water suppression (16 averages) were acquired. Water unsuppressed spectra were used for eddy current correction and as an internal reference to measure metabolites relative to voxel water concentration. DLPFC was selected as the region of interest as it is differentially effected by mTBI, with differences observed using electrophysiological and functional MRI (fMRI) studies (for e.g. [18] ). MRS was performed after sustained activation of DLPFC during the working memory and information processing speed tasks. The voxel was placed using T1-weighted axial and coronal structural scans and anatomical landmarks, in the area of DLPFC as reported in an fMRI n-Back metaanalysis [19] . When placing the voxel, care was taken so that the voxel contained no cerebrospinal fluid, and extravoxel lipid saturation bands were used. Each spectrum was assessed to ensure good quality (e.g. poor water signal suppression, subject motion or insufficient magnetic field shimming) and absence of artefacts. The spectra obtained were processed using LC Model [20] , using the default settings of water scaling, to obtain metabolite concentrations (total Cr, total Cho, total NAA, myoinositol and glutamate/glutamine, all Cramér-Rao lower bound < 15%), relative to water. Metabolite ratios were also calculated to reduce individual variability: NAA/Cho and Cr/Cho.
Statistics
A series of one-way analyses of variance (ANOVAs), with post-hoc Bonferroni-corrected comparisons, were performed on the participant demographics and questionnaires. The exception was sex, which was tested using w 2 . The cognitive tests were analysed using a mixed-model ANOVA with factor difficulty level (3-Back, 2-Back, 1-Back, 0-Back or 1, 1.5, 2, 2.5 s) and between-subjects factor of group (control, mTBI -PCS, mTBI + PCS).
Metabolite concentrations were analysed using a univariate ANOVA with factor group (mTBI + PCS, mTBI -PCS, control), and Bonferroni-adjusted post-hoc comparisons. Following on from this, univariate ANOVAs with factor mTBI [mTBI (mTBI + PCS/mTBI -PCS); control] and PCS [PCS; no PCS (mTBI -PCS/control)] were carried out. Associations between metabolites, participant demographics and behavioural data were explored across groups (N = 24) using Pearson's correlations where the data were normally distributed and Spearman's r where the assumption of normality was violated. 
Results
Questionnaires and cognitive testing Significant group differences (Table 1) 
Discussion
The present pilot study aimed to explore the metabolic alterations in chronic mTBI and their relationship to reported PCS symptoms. It provides initial evidence for residual metabolic changes, as participants with chronic mTBI exhibited lower Cr/Cho ratio compared with nonhead-injured controls (Fig. 1b) . However, the trend for lower Cr/Cho in those with PCS, along with a trend for correlation between PCS symptom report (RPQ) and Cr/Cho ratio is not currently enough to substantiate an association between these metabolite profiles and PCS diagnosis. Nevertheless, these results suggest an intriguing avenue for future research.
Changes in brain metabolism in mild traumatic brain injury
This study was particularly focused on alterations in metabolites used in energy metabolism, such as Cr, in chronic mTBI. Cr is involved in energy buffering and transport [5] , impairment of its function leads to symptoms similar to those seen in PCS, and supplementation of Cr can improve symptoms after injury [21, 22] . However, there was no difference in cognitive performance between groups in this study and no correlation between performance and Cr.
Furthermore, it was only the Cr/Cho ratio that was significantly different between groups, with no significant change in either absolute Cr or absolute Cho concentration. Therefore, we cannot be certain whether the low Cr/Cho ratio is due to low Cr concentration, a high Cho concentration or a combination of both of these. Indeed, higher Cho has been seen in previous studies in acute mTBI [23] , and could be indicative of neural inflammation or demyelination.
The present study illustrates a metabolic difference between participants with mTBI and non-head-injured controls, even a year after injury. However, it cannot definitively conclude that this difference is due to alterations in energy metabolism (reduced Cr), and not inflammation or cell damage (increased Cho).
Association with postconcussion syndrome
The second aim of this experiment was to investigate whether lasting metabolite changes may be related to the severity of PCS symptoms. There was some suggestion that Cr/Cho ratio is reduced in those with PCS, and decreases in relation to greater RPQ symptom report. This offers some support for the hypothesis that those mTBI participants with higher PCS symptoms will have greater metabolic alterations. However, the correlation was only a trend (P = 0.07), and no correlation was observed when looking at mTBI participants alone (P = 0.8). As such, the present study does not provide substantial enough evidence for our initial hypothesis.
Association with cognitive performance
Lower NAA/Cho ratio correlated with poorer cognitive performance in the hardest PVSAT condition. A similar association has been reported for the PASAT (an auditory version of the same task) in moderate-to-severe TBI [24] . However, there was also a significant correlation between higher total Cho concentration and poorer cognitive performance in the hardest PVSAT condition. The observed NAA/Cho ratio correlation could therefore be purely because of increased Cho in those with worse cognitive performance, or a combination lower NAA and higher Cho concentration. The association of increased Cho and cognitive performance is intriguing, especially in conjunction with the reduced Cr/Cho ratio in mTBI participants.
Future directions
This pilot study provides tentative evidence of sustained changes in brain metabolism over a year after the episode of mild head injury. However, a larger scale follow-up experiment is required to examine our hypothesis more thoroughly and substantiate the more tentative findings.
The variability inherent to mTBI may have masked subtle changes in both absolute Cr or Cho concentration and cognitive performance. Participants taking part in this study had previously undertaken longer versions of the two cognitive tasks as part of a larger sample, with results showing that those with mTBI + PCS performed significantly worse on both tasks [14] . The lack of similar findings in this task could be because of the smaller sample size, fewer trial repetitions in the shorter task used here, or the novel MRI environment. In this study, participants with mTBI + PCS reported higher subjective cognitive failures, PCS symptoms and sleep problems, suggesting that there are indeed some on-going behavioural problems.
In addition, Cr and Cho concentration increased with greater age, as seen in previous research [25] . This potentially limits the interpretation of the results, as another factor (age) is shown to systematically alter the metabolites of interest. However, there is no significant effect of age between the groups, suggesting that the distributions of the ages within the groups are similar, despite numerically different group means. Indeed, if we add age as a covariate to the analysis there is still a significant reduction in Cr/Cho in mTBI participants compared with controls [F(2, 21) = 3.6, P = 0.04], suggesting that it is unlikely to be causing the observed results. Future analyses will need to age-match the groups to factor out this potential confound. Another potential limitation is that although corrections and modifications were made for cerebrospinal fluid contamination, it was not possible to perform tissue segmentation to look at volume effects of grey and white matter. As metabolite concentrations differ between these two tissue types, this could confound the results.
If a larger scale study was able to find equivocal evidence of a reduction in Cr concentration in chronic mTBI, then it would suggest that dietary supplementation of Cr may benefit those with chronic mTBI. Previous studies have observed that Cr supplementation immediately after brain injury improved cognitive function, relieved headaches, dizziness and fatigue, reduced cell damage and post-traumatic amnesia and improved personality and communication [21, 22] . However, Cr has only been administered in the acute phase of TBI, as soon as possible after the injury; it would be interesting to see if the effect is similar in participants with persistent PCS.
Conclusion
This is the first experiment to investigate metabolite changes in chronic mTBI at least a year after injury. Our data suggest that patients with mTBI do exhibit some ongoing metabolic changes, with a reduction in Cr/Cho ratio. However, evidence for the association of this metabolic change with PCS symptom report was not substantial enough to warrant a definitive conclusion. A follow-up study with a larger sample is needed to confirm and expand upon the findings from this pilot work.
